Schroder, W.(2005). A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer. Journal of Clinical Oncology, 23(16_suppl), 5042-5042. doi:10.1200/jco.2005.23.16_suppl.5042

Schroder, W. "A Phase IB, Open Label, Safety and Pharmacokinetic (PK) Study of Escalating Doses of PTK787/ZK 222584 in Combination With Paclitaxel and Carboplatin in Patients (PTs) With Stage IIC to IV Epithelial Ovarian Cancer". Journal of Clinical Oncology, 23.16_suppl ( 2005 ): 5042-5042.